Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Histone demethylase GASC1, a potential prognostic and predictive marker in esophageal squamous cell carcinoma.

Sun LL, Holowatyj A, Xu XE, Wu JY, Wu ZY, Shen JH, Wang SH, Li EM, Yang ZQ, Xu LY.

Am J Cancer Res. 2013 Nov 1;3(5):509-17. eCollection 2013.

2.

Histone demethylase GASC1--a potential prognostic and predictive marker in invasive breast cancer.

Berdel B, Nieminen K, Soini Y, Tengström M, Malinen M, Kosma VM, Palvimo JJ, Mannermaa A.

BMC Cancer. 2012 Nov 14;12:516. doi: 10.1186/1471-2407-12-516.

3.

A three-gene signature and clinical outcome in esophageal squamous cell carcinoma.

Sun LL, Wu JY, Wu ZY, Shen JH, Xu XE, Chen B, Wang SH, Li EM, Xu LY.

Int J Cancer. 2015 Mar 15;136(6):E569-77. doi: 10.1002/ijc.29211. Epub 2014 Sep 24.

4.

GASC1 expression in lung carcinoma is associated with smoking and prognosis of squamous cell carcinoma.

Uimonen K, Merikallio H, Pääkkö P, Harju T, Mannermaa A, Palvimo J, Kosma VM, Soini Y.

Histol Histopathol. 2014 Jun;29(6):797-804. doi: 10.14670/HH-29.797. Epub 2013 Dec 27.

PMID:
24371038
5.

Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer.

Liu G, Bollig-Fischer A, Kreike B, van de Vijver MJ, Abrams J, Ethier SP, Yang ZQ.

Oncogene. 2009 Dec 17;28(50):4491-500. doi: 10.1038/onc.2009.297. Epub 2009 Sep 28.

6.

Expression of Bmi-1 and PAI-1 in esophageal squamous cell carcinoma.

Zhang Y, Zhang YL, Chen HM, Pu HW, Ma WJ, Li XM, Ma H, Chen X.

World J Gastroenterol. 2014 May 14;20(18):5533-9. doi: 10.3748/wjg.v20.i18.5533.

7.

Overexpression of Jumonji AT-rich interactive domain 1B and PHD finger protein 2 is involved in the progression of esophageal squamous cell carcinoma.

Sun LL, Sun XX, Xu XE, Zhu MX, Wu ZY, Shen JH, Wu JY, Huang Q, Li EM, Xu LY.

Acta Histochem. 2013 Jan;115(1):56-62. doi: 10.1016/j.acthis.2012.04.001. Epub 2012 Apr 23.

PMID:
22534467
8.

Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.

Yang ZT, Yeo SY, Yin YX, Lin ZH, Lee HM, Xuan YH, Cui Y, Kim SH.

PLoS One. 2016 Jan 5;11(1):e0145807. doi: 10.1371/journal.pone.0145807. eCollection 2016.

9.

Analysis of HAX-1 gene expression in esophageal squamous cell carcinoma.

Li M, Tang Y, Zang W, Xuan X, Wang N, Ma Y, Wang Y, Dong Z, Zhao G.

Diagn Pathol. 2013 Mar 25;8:47. doi: 10.1186/1746-1596-8-47.

10.

The oncogenic role of GASC1 in chemically induced mouse skin cancer.

Ozaki Y, Fujiwara K, Ikeda M, Ozaki T, Terui T, Soma M, Inazawa J, Nagase H.

Mamm Genome. 2015 Dec;26(11-12):591-7. doi: 10.1007/s00335-015-9592-9. Epub 2015 Aug 7.

PMID:
26248577
11.

Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.

Hsu PK, Kao HL, Chen HY, Yen CC, Wu YC, Hsu WH, Chou TY.

J Thorac Cardiovasc Surg. 2014 May;147(5):1612-1618.e4. doi: 10.1016/j.jtcvs.2013.09.066. Epub 2013 Nov 19.

12.

Integrin α5 promotes tumor progression and is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma.

Xie JJ, Guo JC, Wu ZY, Xu XE, Wu JY, Chen B, Ran LQ, Liao LD, Li EM, Xu LY.

Hum Pathol. 2016 Feb;48:69-75. doi: 10.1016/j.humpath.2015.09.029. Epub 2015 Oct 22.

PMID:
26772401
13.

Overexpression of GRB2 is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.

Li LY, Li EM, Wu ZY, Cao HH, Shen JH, Xu XE, Chen B, Wu JY, Xu LY.

Int J Clin Exp Pathol. 2014 May 15;7(6):3132-40. eCollection 2014.

14.

Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.

Sakai M, Kato H, Sano A, Tanaka N, Inose T, Kimura H, Sohda M, Nakajima M, Kuwano H.

Ann Surg Oncol. 2009 Sep;16(9):2494-501. doi: 10.1245/s10434-009-0559-5. Epub 2009 Jun 13.

PMID:
19526206
15.

Expression of Wnt11 and Rock2 protein with clinical characteristics of esophageal squamous cell carcinoma in Kazakh and Han patients.

Liu D, Zhou K, Li Q, Deng F, Ma Y.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):7122-30. eCollection 2015.

16.

The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.

Wang WS, Zhong HJ, Xiao DW, Huang X, Liao LD, Xie ZF, Xu XE, Shen ZY, Xu LY, Li EM.

Dis Esophagus. 2010 Aug;23(6):512-21. doi: 10.1111/j.1442-2050.2009.01035.x. Epub 2010 Jan 20.

PMID:
20095995
17.

The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3.

Cloos PA, Christensen J, Agger K, Maiolica A, Rappsilber J, Antal T, Hansen KH, Helin K.

Nature. 2006 Jul 20;442(7100):307-11. Epub 2006 May 28.

PMID:
16732293
18.

Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China.

Wang Y, Zhe H, Gao P, Zhang N, Li G, Qin J.

Dis Esophagus. 2012 Aug;25(6):560-5. doi: 10.1111/j.1442-2050.2011.01279.x. Epub 2011 Nov 18.

PMID:
22098156
19.

Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.

Yu VZ, Wong VC, Dai W, Ko JM, Lam AK, Chan KW, Samant RS, Lung HL, Shuen WH, Law S, Chan YP, Lee NP, Tong DK, Law TT, Lee VH, Lung ML.

Gastroenterology. 2015 Dec;149(7):1825-1836.e5. doi: 10.1053/j.gastro.2015.08.025. Epub 2015 Aug 22.

PMID:
26302489
20.

κ-Opioid receptor in the nucleus is a novel prognostic factor of esophageal squamous cell carcinoma.

Zhang YF, Xu QX, Liao LD, Xu XE, Wu JY, Shen J, Wu ZY, Shen JH, Li EM, Xu LY.

Hum Pathol. 2013 Sep;44(9):1756-65. doi: 10.1016/j.humpath.2012.11.025. Epub 2013 Apr 8.

PMID:
23574786

Supplemental Content

Support Center